M Torres Avisbal, J M Ruíz de Almodovar Rivera, V Pedraza Muriel
{"title":"[乳腺癌残留肿瘤质量及其他动力学参数的临床相关性]。","authors":"M Torres Avisbal, J M Ruíz de Almodovar Rivera, V Pedraza Muriel","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Based on data about illness-free survival obtained studying a group of 192 patients affected by breast cancer, we have made some calculations about tumoral growth kinetics, using the theoretical presumptions of the exponential model. Tumoral recurrence in the different stages (S-I = 35%, S-II = 38%, S-III = 53% y S-IV = 72%) were valued. Also the theoretical mean time of tumoral relapse was determined for each clinical stage of the illness (S-I = 4.6 years, S-II = 2.6 years, S-III = 1.9 years and S-IV = 1.2 years). Knowledge of these relapse time values makes it finally possible to value the residual tumoral mass after treating the primary in each clinical stage under study (S-I = 1.2 X 10(6) cells, S-II = 8.1 X 10(7) cells, S-III = 3.6 X 10(8) cells and E-IV = 1.6 X 10(9) cells). Comparison of the theoretical data obtained with the corresponding clinical data (real appearance time of relapses, percentage of patients of each Stage that have metastasis, etc.) shows that the formulations and theoretical concepts used, describe, with a certain degree of preciseness, the ordinary clinical observations phenomena that characterize the evolutive course of the breast carcinoma.</p>","PeriodicalId":77791,"journal":{"name":"Revista espanola de oncologia","volume":"32 2","pages":"237-53"},"PeriodicalIF":0.0000,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Residual tumor mass and other kinetic parameters of clinical relevance in cancer of the breast].\",\"authors\":\"M Torres Avisbal, J M Ruíz de Almodovar Rivera, V Pedraza Muriel\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Based on data about illness-free survival obtained studying a group of 192 patients affected by breast cancer, we have made some calculations about tumoral growth kinetics, using the theoretical presumptions of the exponential model. Tumoral recurrence in the different stages (S-I = 35%, S-II = 38%, S-III = 53% y S-IV = 72%) were valued. Also the theoretical mean time of tumoral relapse was determined for each clinical stage of the illness (S-I = 4.6 years, S-II = 2.6 years, S-III = 1.9 years and S-IV = 1.2 years). Knowledge of these relapse time values makes it finally possible to value the residual tumoral mass after treating the primary in each clinical stage under study (S-I = 1.2 X 10(6) cells, S-II = 8.1 X 10(7) cells, S-III = 3.6 X 10(8) cells and E-IV = 1.6 X 10(9) cells). Comparison of the theoretical data obtained with the corresponding clinical data (real appearance time of relapses, percentage of patients of each Stage that have metastasis, etc.) shows that the formulations and theoretical concepts used, describe, with a certain degree of preciseness, the ordinary clinical observations phenomena that characterize the evolutive course of the breast carcinoma.</p>\",\"PeriodicalId\":77791,\"journal\":{\"name\":\"Revista espanola de oncologia\",\"volume\":\"32 2\",\"pages\":\"237-53\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1985-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista espanola de oncologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista espanola de oncologia","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
根据对192名乳腺癌患者的无病生存率的研究数据,我们利用指数模型的理论假设,对肿瘤生长动力学进行了一些计算。观察不同分期肿瘤复发率(S-I = 35%, S-II = 38%, S-III = 53%, S-IV = 72%)。此外,还确定了每个临床阶段肿瘤复发的理论平均时间(S-I = 4.6年,S-II = 2.6年,S-III = 1.9年,S-IV = 1.2年)。了解这些复发时间值,最终可以在研究的每个临床阶段(S-I = 1.2 X 10(6)个细胞,S-II = 8.1 X 10(7)个细胞,S-III = 3.6 X 10(8)个细胞,E-IV = 1.6 X 10(9)个细胞)治疗原发肿瘤后对残留肿瘤肿块进行评估。将所得的理论数据与相应的临床数据(复发的真实出现时间、各期发生转移的患者比例等)进行比较,可以看出所使用的公式和理论概念,在一定程度上准确地描述了表征乳腺癌演变过程的普通临床观察现象。
[Residual tumor mass and other kinetic parameters of clinical relevance in cancer of the breast].
Based on data about illness-free survival obtained studying a group of 192 patients affected by breast cancer, we have made some calculations about tumoral growth kinetics, using the theoretical presumptions of the exponential model. Tumoral recurrence in the different stages (S-I = 35%, S-II = 38%, S-III = 53% y S-IV = 72%) were valued. Also the theoretical mean time of tumoral relapse was determined for each clinical stage of the illness (S-I = 4.6 years, S-II = 2.6 years, S-III = 1.9 years and S-IV = 1.2 years). Knowledge of these relapse time values makes it finally possible to value the residual tumoral mass after treating the primary in each clinical stage under study (S-I = 1.2 X 10(6) cells, S-II = 8.1 X 10(7) cells, S-III = 3.6 X 10(8) cells and E-IV = 1.6 X 10(9) cells). Comparison of the theoretical data obtained with the corresponding clinical data (real appearance time of relapses, percentage of patients of each Stage that have metastasis, etc.) shows that the formulations and theoretical concepts used, describe, with a certain degree of preciseness, the ordinary clinical observations phenomena that characterize the evolutive course of the breast carcinoma.